TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT
Authors:
- Eleanna KaraEKEleanna Kara
- Rina BandopadhyayRBRina Bandopadhyay
- John HardyJHJohn Hardy
- Janice HoltonJHJanice Holton
- Georgia XiromerisiouGXGeorgia Xiromerisiou
- Andrew LeesALAndrew Lees
- Henry HouldenHHHenry Houlden
- Tamas ReveszTRTamas Revesz
Open Access
- 1 December 2013
- journal article
- case report
- Published by Elsevier in Neurobiology of Aging
- Vol. 34 (12) , 2889.e5-2889.e9
Abstract
No abstract availableKeywords
Funding Information
- PSP (Europe) Association Research Fellowship Grant
- Wellcome Trust/MRC Joint Call in Neurodegeneration
- National Institute for Health Research
- University College London
This publication has 47 references indexed in Scilit:
- Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variantActa Neuropathologica, 2012
- High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)Movement Disorders, 2011
- Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsyActa Neuropathologica, 2010
- Cross Currents in Protein Misfolding Disorders: Interactions and TherapyCNS & Neurological Disorders - Drug Targets, 2009
- Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutationsMovement Disorders, 2009
- LRRK2 and neurodegenerationActa Neuropathologica, 2009
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusionsActa Neuropathologica, 2006
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathologica, 2006
- Autosomal Dominant Familial Parkinson Disease: Older Onset of Age, and Good Response to Levodopa TherapyEuropean Neurology, 1997